nodes	percent_of_prediction	percent_of_DWPC	metapath
Adefovir Dipivoxil—hepatitis B—liver cancer	0.871	1	CtDrD
Adefovir Dipivoxil—ABCC4—Sorafenib—liver cancer	0.0589	1	CbGbCtD
Adefovir Dipivoxil—Hypophosphataemia—Sorafenib—liver cancer	0.00153	0.0456	CcSEcCtD
Adefovir Dipivoxil—Hepatic function abnormal—Sorafenib—liver cancer	0.00074	0.022	CcSEcCtD
Adefovir Dipivoxil—Hepatic failure—Sorafenib—liver cancer	0.00072	0.0214	CcSEcCtD
Adefovir Dipivoxil—Kidney function abnormal—Epirubicin—liver cancer	0.000681	0.0203	CcSEcCtD
Adefovir Dipivoxil—Kidney function abnormal—Doxorubicin—liver cancer	0.000631	0.0187	CcSEcCtD
Adefovir Dipivoxil—Alanine aminotransferase increased—Sorafenib—liver cancer	0.000571	0.017	CcSEcCtD
Adefovir Dipivoxil—Hypophosphataemia—Epirubicin—liver cancer	0.000567	0.0168	CcSEcCtD
Adefovir Dipivoxil—Pancreatitis—Sorafenib—liver cancer	0.000548	0.0163	CcSEcCtD
Adefovir Dipivoxil—Serum creatinine increased—Epirubicin—liver cancer	0.000535	0.0159	CcSEcCtD
Adefovir Dipivoxil—Hypophosphataemia—Doxorubicin—liver cancer	0.000524	0.0156	CcSEcCtD
Adefovir Dipivoxil—Weight decreased—Sorafenib—liver cancer	0.000506	0.015	CcSEcCtD
Adefovir Dipivoxil—Serum creatinine increased—Doxorubicin—liver cancer	0.000495	0.0147	CcSEcCtD
Adefovir Dipivoxil—Renal failure—Sorafenib—liver cancer	0.00049	0.0146	CcSEcCtD
Adefovir Dipivoxil—Jaundice—Sorafenib—liver cancer	0.000486	0.0144	CcSEcCtD
Adefovir Dipivoxil—Hepatobiliary disease—Sorafenib—liver cancer	0.000471	0.014	CcSEcCtD
Adefovir Dipivoxil—Urinary tract disorder—Sorafenib—liver cancer	0.000442	0.0131	CcSEcCtD
Adefovir Dipivoxil—Connective tissue disorder—Sorafenib—liver cancer	0.00044	0.0131	CcSEcCtD
Adefovir Dipivoxil—Urethral disorder—Sorafenib—liver cancer	0.000439	0.013	CcSEcCtD
Adefovir Dipivoxil—Glycosuria—Epirubicin—liver cancer	0.000407	0.0121	CcSEcCtD
Adefovir Dipivoxil—Malnutrition—Sorafenib—liver cancer	0.00039	0.0116	CcSEcCtD
Adefovir Dipivoxil—Glycosuria—Doxorubicin—liver cancer	0.000376	0.0112	CcSEcCtD
Adefovir Dipivoxil—Anaemia—Sorafenib—liver cancer	0.00036	0.0107	CcSEcCtD
Adefovir Dipivoxil—Cough increased—Epirubicin—liver cancer	0.00036	0.0107	CcSEcCtD
Adefovir Dipivoxil—Creatinine increased—Epirubicin—liver cancer	0.000346	0.0103	CcSEcCtD
Adefovir Dipivoxil—Bone pain—Epirubicin—liver cancer	0.000344	0.0102	CcSEcCtD
Adefovir Dipivoxil—Cough—Sorafenib—liver cancer	0.00034	0.0101	CcSEcCtD
Adefovir Dipivoxil—Cough increased—Doxorubicin—liver cancer	0.000333	0.00989	CcSEcCtD
Adefovir Dipivoxil—Myalgia—Sorafenib—liver cancer	0.000332	0.00986	CcSEcCtD
Adefovir Dipivoxil—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—liver cancer	0.000329	0.00979	CcSEcCtD
Adefovir Dipivoxil—Hepatocellular injury—Epirubicin—liver cancer	0.000329	0.00979	CcSEcCtD
Adefovir Dipivoxil—Hyperkalaemia—Epirubicin—liver cancer	0.000324	0.00962	CcSEcCtD
Adefovir Dipivoxil—Creatinine increased—Doxorubicin—liver cancer	0.00032	0.00951	CcSEcCtD
Adefovir Dipivoxil—Bone pain—Doxorubicin—liver cancer	0.000318	0.00945	CcSEcCtD
Adefovir Dipivoxil—Nervous system disorder—Sorafenib—liver cancer	0.000312	0.00927	CcSEcCtD
Adefovir Dipivoxil—Thrombocytopenia—Sorafenib—liver cancer	0.000311	0.00925	CcSEcCtD
Adefovir Dipivoxil—Skin disorder—Sorafenib—liver cancer	0.000309	0.00918	CcSEcCtD
Adefovir Dipivoxil—Hepatocellular injury—Doxorubicin—liver cancer	0.000305	0.00906	CcSEcCtD
Adefovir Dipivoxil—Anorexia—Sorafenib—liver cancer	0.000303	0.00901	CcSEcCtD
Adefovir Dipivoxil—Hyperkalaemia—Doxorubicin—liver cancer	0.000299	0.0089	CcSEcCtD
Adefovir Dipivoxil—Musculoskeletal discomfort—Sorafenib—liver cancer	0.00029	0.00861	CcSEcCtD
Adefovir Dipivoxil—Dyspepsia—Sorafenib—liver cancer	0.00028	0.00832	CcSEcCtD
Adefovir Dipivoxil—Decreased appetite—Sorafenib—liver cancer	0.000276	0.00821	CcSEcCtD
Adefovir Dipivoxil—Gastrointestinal disorder—Sorafenib—liver cancer	0.000275	0.00816	CcSEcCtD
Adefovir Dipivoxil—Hepatic function abnormal—Epirubicin—liver cancer	0.000274	0.00813	CcSEcCtD
Adefovir Dipivoxil—Hepatic failure—Epirubicin—liver cancer	0.000266	0.00791	CcSEcCtD
Adefovir Dipivoxil—Gastrointestinal pain—Sorafenib—liver cancer	0.00026	0.00773	CcSEcCtD
Adefovir Dipivoxil—Hepatic function abnormal—Doxorubicin—liver cancer	0.000253	0.00752	CcSEcCtD
Adefovir Dipivoxil—Abdominal pain—Sorafenib—liver cancer	0.000251	0.00747	CcSEcCtD
Adefovir Dipivoxil—Body temperature increased—Sorafenib—liver cancer	0.000251	0.00747	CcSEcCtD
Adefovir Dipivoxil—Renal impairment—Epirubicin—liver cancer	0.000251	0.00747	CcSEcCtD
Adefovir Dipivoxil—Hepatic failure—Doxorubicin—liver cancer	0.000246	0.00732	CcSEcCtD
Adefovir Dipivoxil—Renal impairment—Doxorubicin—liver cancer	0.000232	0.00691	CcSEcCtD
Adefovir Dipivoxil—Asthenia—Sorafenib—liver cancer	0.000228	0.00678	CcSEcCtD
Adefovir Dipivoxil—Pruritus—Sorafenib—liver cancer	0.000225	0.00669	CcSEcCtD
Adefovir Dipivoxil—Blood creatinine increased—Epirubicin—liver cancer	0.000224	0.00666	CcSEcCtD
Adefovir Dipivoxil—Liver function test abnormal—Epirubicin—liver cancer	0.000221	0.00656	CcSEcCtD
Adefovir Dipivoxil—Diarrhoea—Sorafenib—liver cancer	0.000218	0.00647	CcSEcCtD
Adefovir Dipivoxil—Alanine aminotransferase increased—Epirubicin—liver cancer	0.000211	0.00627	CcSEcCtD
Adefovir Dipivoxil—Blood creatinine increased—Doxorubicin—liver cancer	0.000207	0.00616	CcSEcCtD
Adefovir Dipivoxil—Liver function test abnormal—Doxorubicin—liver cancer	0.000204	0.00607	CcSEcCtD
Adefovir Dipivoxil—Pancreatitis—Epirubicin—liver cancer	0.000203	0.00602	CcSEcCtD
Adefovir Dipivoxil—Vomiting—Sorafenib—liver cancer	0.000202	0.00601	CcSEcCtD
Adefovir Dipivoxil—Rash—Sorafenib—liver cancer	0.0002	0.00596	CcSEcCtD
Adefovir Dipivoxil—Dermatitis—Sorafenib—liver cancer	0.0002	0.00595	CcSEcCtD
Adefovir Dipivoxil—Headache—Sorafenib—liver cancer	0.000199	0.00592	CcSEcCtD
Adefovir Dipivoxil—Alanine aminotransferase increased—Doxorubicin—liver cancer	0.000195	0.0058	CcSEcCtD
Adefovir Dipivoxil—Nausea—Sorafenib—liver cancer	0.000189	0.00561	CcSEcCtD
Adefovir Dipivoxil—Pancreatitis—Doxorubicin—liver cancer	0.000187	0.00557	CcSEcCtD
Adefovir Dipivoxil—Weight decreased—Epirubicin—liver cancer	0.000187	0.00556	CcSEcCtD
Adefovir Dipivoxil—Renal failure—Epirubicin—liver cancer	0.000181	0.00538	CcSEcCtD
Adefovir Dipivoxil—Jaundice—Epirubicin—liver cancer	0.00018	0.00534	CcSEcCtD
Adefovir Dipivoxil—Haematuria—Epirubicin—liver cancer	0.000176	0.00522	CcSEcCtD
Adefovir Dipivoxil—Hepatobiliary disease—Epirubicin—liver cancer	0.000174	0.00518	CcSEcCtD
Adefovir Dipivoxil—Weight decreased—Doxorubicin—liver cancer	0.000173	0.00514	CcSEcCtD
Adefovir Dipivoxil—Sinusitis—Epirubicin—liver cancer	0.000173	0.00514	CcSEcCtD
Adefovir Dipivoxil—Renal failure—Doxorubicin—liver cancer	0.000168	0.00498	CcSEcCtD
Adefovir Dipivoxil—Jaundice—Doxorubicin—liver cancer	0.000166	0.00494	CcSEcCtD
Adefovir Dipivoxil—Hepatitis—Epirubicin—liver cancer	0.000165	0.00492	CcSEcCtD
Adefovir Dipivoxil—Pharyngitis—Epirubicin—liver cancer	0.000164	0.00488	CcSEcCtD
Adefovir Dipivoxil—Urinary tract disorder—Epirubicin—liver cancer	0.000163	0.00485	CcSEcCtD
Adefovir Dipivoxil—Haematuria—Doxorubicin—liver cancer	0.000163	0.00483	CcSEcCtD
Adefovir Dipivoxil—Connective tissue disorder—Epirubicin—liver cancer	0.000163	0.00483	CcSEcCtD
Adefovir Dipivoxil—Urethral disorder—Epirubicin—liver cancer	0.000162	0.00482	CcSEcCtD
Adefovir Dipivoxil—Hepatobiliary disease—Doxorubicin—liver cancer	0.000161	0.00479	CcSEcCtD
Adefovir Dipivoxil—Sinusitis—Doxorubicin—liver cancer	0.00016	0.00475	CcSEcCtD
Adefovir Dipivoxil—Hepatitis—Doxorubicin—liver cancer	0.000153	0.00455	CcSEcCtD
Adefovir Dipivoxil—Pharyngitis—Doxorubicin—liver cancer	0.000152	0.00451	CcSEcCtD
Adefovir Dipivoxil—Urinary tract disorder—Doxorubicin—liver cancer	0.000151	0.00449	CcSEcCtD
Adefovir Dipivoxil—Connective tissue disorder—Doxorubicin—liver cancer	0.00015	0.00447	CcSEcCtD
Adefovir Dipivoxil—Urethral disorder—Doxorubicin—liver cancer	0.00015	0.00446	CcSEcCtD
Adefovir Dipivoxil—Malnutrition—Epirubicin—liver cancer	0.000144	0.00428	CcSEcCtD
Adefovir Dipivoxil—Flatulence—Epirubicin—liver cancer	0.000142	0.00422	CcSEcCtD
Adefovir Dipivoxil—Back pain—Epirubicin—liver cancer	0.000139	0.00414	CcSEcCtD
Adefovir Dipivoxil—Malnutrition—Doxorubicin—liver cancer	0.000133	0.00396	CcSEcCtD
Adefovir Dipivoxil—Anaemia—Epirubicin—liver cancer	0.000133	0.00396	CcSEcCtD
Adefovir Dipivoxil—Flatulence—Doxorubicin—liver cancer	0.000131	0.0039	CcSEcCtD
Adefovir Dipivoxil—Back pain—Doxorubicin—liver cancer	0.000129	0.00383	CcSEcCtD
Adefovir Dipivoxil—Cough—Epirubicin—liver cancer	0.000126	0.00373	CcSEcCtD
Adefovir Dipivoxil—Anaemia—Doxorubicin—liver cancer	0.000123	0.00366	CcSEcCtD
Adefovir Dipivoxil—Myalgia—Epirubicin—liver cancer	0.000123	0.00364	CcSEcCtD
Adefovir Dipivoxil—Chest pain—Epirubicin—liver cancer	0.000123	0.00364	CcSEcCtD
Adefovir Dipivoxil—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—liver cancer	0.000122	0.00362	CcSEcCtD
Adefovir Dipivoxil—Cough—Doxorubicin—liver cancer	0.000116	0.00346	CcSEcCtD
Adefovir Dipivoxil—Nervous system disorder—Epirubicin—liver cancer	0.000115	0.00342	CcSEcCtD
Adefovir Dipivoxil—Thrombocytopenia—Epirubicin—liver cancer	0.000115	0.00342	CcSEcCtD
Adefovir Dipivoxil—Skin disorder—Epirubicin—liver cancer	0.000114	0.00339	CcSEcCtD
Adefovir Dipivoxil—Myalgia—Doxorubicin—liver cancer	0.000113	0.00337	CcSEcCtD
Adefovir Dipivoxil—Chest pain—Doxorubicin—liver cancer	0.000113	0.00337	CcSEcCtD
Adefovir Dipivoxil—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—liver cancer	0.000113	0.00335	CcSEcCtD
Adefovir Dipivoxil—Anorexia—Epirubicin—liver cancer	0.000112	0.00333	CcSEcCtD
Adefovir Dipivoxil—Musculoskeletal discomfort—Epirubicin—liver cancer	0.000107	0.00318	CcSEcCtD
Adefovir Dipivoxil—Nervous system disorder—Doxorubicin—liver cancer	0.000107	0.00317	CcSEcCtD
Adefovir Dipivoxil—Thrombocytopenia—Doxorubicin—liver cancer	0.000106	0.00316	CcSEcCtD
Adefovir Dipivoxil—Skin disorder—Doxorubicin—liver cancer	0.000106	0.00314	CcSEcCtD
Adefovir Dipivoxil—Anorexia—Doxorubicin—liver cancer	0.000104	0.00308	CcSEcCtD
Adefovir Dipivoxil—Dyspepsia—Epirubicin—liver cancer	0.000103	0.00307	CcSEcCtD
Adefovir Dipivoxil—Decreased appetite—Epirubicin—liver cancer	0.000102	0.00304	CcSEcCtD
Adefovir Dipivoxil—Gastrointestinal disorder—Epirubicin—liver cancer	0.000101	0.00302	CcSEcCtD
Adefovir Dipivoxil—Musculoskeletal discomfort—Doxorubicin—liver cancer	9.91e-05	0.00294	CcSEcCtD
Adefovir Dipivoxil—Gastrointestinal pain—Epirubicin—liver cancer	9.61e-05	0.00286	CcSEcCtD
Adefovir Dipivoxil—Dyspepsia—Doxorubicin—liver cancer	9.57e-05	0.00284	CcSEcCtD
Adefovir Dipivoxil—Decreased appetite—Doxorubicin—liver cancer	9.45e-05	0.00281	CcSEcCtD
Adefovir Dipivoxil—Gastrointestinal disorder—Doxorubicin—liver cancer	9.39e-05	0.00279	CcSEcCtD
Adefovir Dipivoxil—Abdominal pain—Epirubicin—liver cancer	9.29e-05	0.00276	CcSEcCtD
Adefovir Dipivoxil—Body temperature increased—Epirubicin—liver cancer	9.29e-05	0.00276	CcSEcCtD
Adefovir Dipivoxil—Gastrointestinal pain—Doxorubicin—liver cancer	8.89e-05	0.00264	CcSEcCtD
Adefovir Dipivoxil—Abdominal pain—Doxorubicin—liver cancer	8.59e-05	0.00255	CcSEcCtD
Adefovir Dipivoxil—Body temperature increased—Doxorubicin—liver cancer	8.59e-05	0.00255	CcSEcCtD
Adefovir Dipivoxil—Asthenia—Epirubicin—liver cancer	8.43e-05	0.00251	CcSEcCtD
Adefovir Dipivoxil—Pruritus—Epirubicin—liver cancer	8.31e-05	0.00247	CcSEcCtD
Adefovir Dipivoxil—Diarrhoea—Epirubicin—liver cancer	8.04e-05	0.00239	CcSEcCtD
Adefovir Dipivoxil—Asthenia—Doxorubicin—liver cancer	7.8e-05	0.00232	CcSEcCtD
Adefovir Dipivoxil—Pruritus—Doxorubicin—liver cancer	7.69e-05	0.00229	CcSEcCtD
Adefovir Dipivoxil—Vomiting—Epirubicin—liver cancer	7.47e-05	0.00222	CcSEcCtD
Adefovir Dipivoxil—Diarrhoea—Doxorubicin—liver cancer	7.44e-05	0.00221	CcSEcCtD
Adefovir Dipivoxil—Rash—Epirubicin—liver cancer	7.41e-05	0.0022	CcSEcCtD
Adefovir Dipivoxil—Dermatitis—Epirubicin—liver cancer	7.4e-05	0.0022	CcSEcCtD
Adefovir Dipivoxil—Headache—Epirubicin—liver cancer	7.36e-05	0.00219	CcSEcCtD
Adefovir Dipivoxil—Nausea—Epirubicin—liver cancer	6.98e-05	0.00207	CcSEcCtD
Adefovir Dipivoxil—Vomiting—Doxorubicin—liver cancer	6.91e-05	0.00205	CcSEcCtD
Adefovir Dipivoxil—Rash—Doxorubicin—liver cancer	6.86e-05	0.00204	CcSEcCtD
Adefovir Dipivoxil—Dermatitis—Doxorubicin—liver cancer	6.85e-05	0.00204	CcSEcCtD
Adefovir Dipivoxil—Headache—Doxorubicin—liver cancer	6.81e-05	0.00202	CcSEcCtD
Adefovir Dipivoxil—Nausea—Doxorubicin—liver cancer	6.46e-05	0.00192	CcSEcCtD
Adefovir Dipivoxil—NME1—Metabolism—GSTA4—liver cancer	6.18e-05	0.00172	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Metabolism—HPGDS—liver cancer	6.06e-05	0.00168	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Transmembrane transport of small molecules—SLC40A1—liver cancer	6.06e-05	0.00168	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A8—Transmembrane transport of small molecules—ANXA2—liver cancer	6.06e-05	0.00168	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A8—Transmembrane transport of small molecules—ATP7B—liver cancer	6.06e-05	0.00168	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—GSTA2—liver cancer	6.02e-05	0.00167	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—EPT1—liver cancer	5.97e-05	0.00166	CbGpPWpGaD
Adefovir Dipivoxil—AK2—Metabolism—GSTP1—liver cancer	5.87e-05	0.00163	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—GSTA1—liver cancer	5.81e-05	0.00161	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Transmembrane transport of small molecules—ATP7B—liver cancer	5.81e-05	0.00161	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Transmembrane transport of small molecules—ANXA2—liver cancer	5.81e-05	0.00161	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Integrated Pancreatic Cancer Pathway—TNF—liver cancer	5.8e-05	0.00161	CbGpPWpGaD
Adefovir Dipivoxil—AK2—Metabolism—HMOX1—liver cancer	5.79e-05	0.00161	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Integrated Pancreatic Cancer Pathway—KRAS—liver cancer	5.76e-05	0.0016	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—NAT2—liver cancer	5.74e-05	0.00159	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A8—Transmembrane transport of small molecules—NR1H4—liver cancer	5.73e-05	0.00159	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Platelet activation, signaling and aggregation—PRKCE—liver cancer	5.68e-05	0.00158	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—TAT—liver cancer	5.66e-05	0.00157	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A6—Transmembrane transport of small molecules—SLC11A2—liver cancer	5.53e-05	0.00153	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—ALDOB—liver cancer	5.51e-05	0.00153	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Transmembrane transport of small molecules—NR1H4—liver cancer	5.49e-05	0.00152	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Metabolism—PSMA4—liver cancer	5.4e-05	0.0015	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Metabolism—PSMD10—liver cancer	5.4e-05	0.0015	CbGpPWpGaD
Adefovir Dipivoxil—AK2—Metabolism—GSTM1—liver cancer	5.4e-05	0.0015	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Platelet activation, signaling and aggregation—IGF2—liver cancer	5.38e-05	0.00149	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Integrated Pancreatic Cancer Pathway—PIK3CA—liver cancer	5.29e-05	0.00147	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A6—Transmembrane transport of small molecules—SLC40A1—liver cancer	5.27e-05	0.00146	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Metabolism—GOT2—liver cancer	5.25e-05	0.00146	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—CRABP1—liver cancer	5.25e-05	0.00146	CbGpPWpGaD
Adefovir Dipivoxil—AK2—Metabolism—CYP1A1—liver cancer	5.12e-05	0.00142	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Integrated Pancreatic Cancer Pathway—TP53—liver cancer	5.12e-05	0.00142	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—UGDH—liver cancer	5.09e-05	0.00141	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Platelet degranulation—VEGFA—liver cancer	5.09e-05	0.00141	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Platelet activation, signaling and aggregation—HGF—liver cancer	5.08e-05	0.00141	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A6—Transmembrane transport of small molecules—ATP7B—liver cancer	5.05e-05	0.0014	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A6—Transmembrane transport of small molecules—ANXA2—liver cancer	5.05e-05	0.0014	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Platelet activation, signaling and aggregation—CSF2—liver cancer	5.02e-05	0.00139	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Metabolism—CYP2E1—liver cancer	4.94e-05	0.00137	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Response to elevated platelet cytosolic Ca2+—VEGFA—liver cancer	4.84e-05	0.00135	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—EPT1—liver cancer	4.79e-05	0.00133	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A6—Transmembrane transport of small molecules—NR1H4—liver cancer	4.78e-05	0.00133	CbGpPWpGaD
Adefovir Dipivoxil—AK2—Metabolism—MTHFR—liver cancer	4.77e-05	0.00133	CbGpPWpGaD
Adefovir Dipivoxil—AK2—Metabolism—PPARA—liver cancer	4.68e-05	0.0013	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Platelet degranulation—TGFB1—liver cancer	4.67e-05	0.0013	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Metabolism—CYCS—liver cancer	4.62e-05	0.00128	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—LTF—liver cancer	4.59e-05	0.00128	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—HPGDS—liver cancer	4.59e-05	0.00127	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—TAT—liver cancer	4.54e-05	0.00126	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Metabolism—GGT1—liver cancer	4.53e-05	0.00126	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Metabolism—GOT1—liver cancer	4.53e-05	0.00126	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Response to elevated platelet cytosolic Ca2+—TGFB1—liver cancer	4.45e-05	0.00123	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—SERPINA1—liver cancer	4.44e-05	0.00123	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Integrated Pancreatic Cancer Pathway—AKT1—liver cancer	4.32e-05	0.0012	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—NRF2 pathway—TGFB1—liver cancer	4.16e-05	0.00116	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—PSMA4—liver cancer	4.09e-05	0.00114	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—PSMD10—liver cancer	4.09e-05	0.00114	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Metabolism—GSTP1—liver cancer	4.07e-05	0.00113	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Platelet activation, signaling and aggregation—MAPK14—liver cancer	4.07e-05	0.00113	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Transmembrane transport of small molecules—CYCS—liver cancer	4.04e-05	0.00112	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Metabolism—HMOX1—liver cancer	4.02e-05	0.00112	CbGpPWpGaD
Adefovir Dipivoxil—AK2—Metabolism—PIK3CG—liver cancer	4.01e-05	0.00111	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—GOT2—liver cancer	3.98e-05	0.00111	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Platelet activation, signaling and aggregation—F2—liver cancer	3.94e-05	0.00109	CbGpPWpGaD
Adefovir Dipivoxil—AK2—Metabolism—PPARG—liver cancer	3.87e-05	0.00107	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—CPT1B—liver cancer	3.85e-05	0.00107	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—GLUL—liver cancer	3.85e-05	0.00107	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Platelet activation, signaling and aggregation—PIK3CG—liver cancer	3.77e-05	0.00105	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Metabolism—GSTM1—liver cancer	3.74e-05	0.00104	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—CYP2E1—liver cancer	3.74e-05	0.00104	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Ectoderm Differentiation—CTNNB1—liver cancer	3.73e-05	0.00104	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—NR1H4—liver cancer	3.71e-05	0.00103	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—GSTA3—liver cancer	3.65e-05	0.00101	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—ALDOB—liver cancer	3.55e-05	0.000986	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Metabolism—CYP1A1—liver cancer	3.55e-05	0.000985	CbGpPWpGaD
Adefovir Dipivoxil—AK2—Metabolism—PIK3CD—liver cancer	3.52e-05	0.000979	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Transmembrane transport of small molecules—HMOX1—liver cancer	3.51e-05	0.000975	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—CYCS—liver cancer	3.5e-05	0.000972	CbGpPWpGaD
Adefovir Dipivoxil—AK2—Metabolism—ALB—liver cancer	3.48e-05	0.000966	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—GGT1—liver cancer	3.44e-05	0.000954	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—GOT1—liver cancer	3.44e-05	0.000954	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—GSTA4—liver cancer	3.34e-05	0.000926	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—SLC-mediated transmembrane transport—ALB—liver cancer	3.33e-05	0.000924	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Platelet activation, signaling and aggregation—PIK3CD—liver cancer	3.32e-05	0.000921	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—IFNA1—liver cancer	3.31e-05	0.000919	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Metabolism—MTHFR—liver cancer	3.31e-05	0.000919	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Platelet activation, signaling and aggregation—SERPINE1—liver cancer	3.28e-05	0.000911	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Platelet activation, signaling and aggregation—ALB—liver cancer	3.27e-05	0.000909	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—GSTA2—liver cancer	3.25e-05	0.000903	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Metabolism—PPARA—liver cancer	3.24e-05	0.000901	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Transmembrane transport of small molecules—CYCS—liver cancer	3.24e-05	0.000899	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—GSTA1—liver cancer	3.14e-05	0.000871	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—NAT2—liver cancer	3.1e-05	0.000861	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—GSTP1—liver cancer	3.09e-05	0.000857	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—CPT1B—liver cancer	3.09e-05	0.000857	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—GLUL—liver cancer	3.09e-05	0.000857	CbGpPWpGaD
Adefovir Dipivoxil—AK2—Metabolism—PIK3CB—liver cancer	3.07e-05	0.000853	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—HMOX1—liver cancer	3.04e-05	0.000845	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Ectoderm Differentiation—MYC—liver cancer	3.02e-05	0.00084	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A8—SLC-mediated transmembrane transport—ALB—liver cancer	3e-05	0.000833	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—NR1H4—liver cancer	2.98e-05	0.000826	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—ALDOB—liver cancer	2.97e-05	0.000826	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Platelet activation, signaling and aggregation—RAF1—liver cancer	2.96e-05	0.000822	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—PRKCE—liver cancer	2.93e-05	0.000813	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—GSTA3—liver cancer	2.92e-05	0.000812	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A8—Transmembrane transport of small molecules—CYCS—liver cancer	2.92e-05	0.000811	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Platelet activation, signaling and aggregation—PIK3CB—liver cancer	2.89e-05	0.000803	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—NRF2 pathway—TGFB1—liver cancer	2.88e-05	0.000801	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—GSTM1—liver cancer	2.84e-05	0.000788	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—CRABP1—liver cancer	2.84e-05	0.000788	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Transmembrane transport of small molecules—PPARA—liver cancer	2.84e-05	0.000787	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Transmembrane transport of small molecules—HMOX1—liver cancer	2.81e-05	0.000782	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—ADAM17—liver cancer	2.81e-05	0.000779	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Transmembrane transport of small molecules—CYCS—liver cancer	2.8e-05	0.000777	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—ABL1—liver cancer	2.78e-05	0.000773	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Metabolism—PIK3CG—liver cancer	2.78e-05	0.000772	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—IGF2—liver cancer	2.77e-05	0.00077	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—CYP1A1—liver cancer	2.69e-05	0.000747	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Metabolism—PPARG—liver cancer	2.68e-05	0.000745	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—GSTA4—liver cancer	2.68e-05	0.000743	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Platelet activation, signaling and aggregation—IL2—liver cancer	2.65e-05	0.000737	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—PSMA4—liver cancer	2.64e-05	0.000733	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—PSMD10—liver cancer	2.64e-05	0.000733	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—HGF—liver cancer	2.62e-05	0.000727	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—GSTA2—liver cancer	2.61e-05	0.000724	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—CSF2—liver cancer	2.59e-05	0.000719	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—GOT2—liver cancer	2.57e-05	0.000713	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A8—Transmembrane transport of small molecules—HMOX1—liver cancer	2.54e-05	0.000705	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—GSTA1—liver cancer	2.52e-05	0.000699	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—MTHFR—liver cancer	2.51e-05	0.000696	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A6—SLC-mediated transmembrane transport—ALB—liver cancer	2.5e-05	0.000695	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—NAT2—liver cancer	2.49e-05	0.000691	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—HPGDS—liver cancer	2.48e-05	0.000688	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—PPARA—liver cancer	2.46e-05	0.000683	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Metabolism—PIK3CD—liver cancer	2.44e-05	0.000678	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A6—Transmembrane transport of small molecules—CYCS—liver cancer	2.44e-05	0.000677	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Transmembrane transport of small molecules—HMOX1—liver cancer	2.43e-05	0.000676	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Metabolism—ALB—liver cancer	2.41e-05	0.00067	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—ALDOB—liver cancer	2.38e-05	0.000662	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—CRABP1—liver cancer	2.27e-05	0.000632	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Transmembrane transport of small molecules—PPARA—liver cancer	2.27e-05	0.000632	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Platelet activation, signaling and aggregation—VEGFA—liver cancer	2.26e-05	0.000626	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—GOT1—liver cancer	2.22e-05	0.000615	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—PSMD10—liver cancer	2.21e-05	0.000614	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—PSMA4—liver cancer	2.21e-05	0.000614	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—GOT2—liver cancer	2.15e-05	0.000597	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Metabolism—PIK3CB—liver cancer	2.13e-05	0.000591	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A6—Transmembrane transport of small molecules—HMOX1—liver cancer	2.12e-05	0.000588	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Transmembrane transport of small molecules—ALB—liver cancer	2.11e-05	0.000585	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—PIK3CG—liver cancer	2.11e-05	0.000585	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—MAPK14—liver cancer	2.1e-05	0.000582	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Platelet activation, signaling and aggregation—TGFB1—liver cancer	2.07e-05	0.000575	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A8—Transmembrane transport of small molecules—PPARA—liver cancer	2.05e-05	0.000569	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—PRKCE—liver cancer	2.04e-05	0.000568	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—PPARG—liver cancer	2.03e-05	0.000564	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—F2—liver cancer	2.03e-05	0.000564	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—CYP2E1—liver cancer	2.02e-05	0.000561	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—HPGDS—liver cancer	1.99e-05	0.000552	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Transmembrane transport of small molecules—PPARA—liver cancer	1.97e-05	0.000546	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—PIK3CG—liver cancer	1.94e-05	0.00054	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Transmembrane transport of small molecules—RAF1—liver cancer	1.91e-05	0.000529	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—CYCS—liver cancer	1.89e-05	0.000525	CbGpPWpGaD
Adefovir Dipivoxil—AK2—Metabolism—PIK3CA—liver cancer	1.87e-05	0.00052	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—GGT1—liver cancer	1.86e-05	0.000515	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—GOT1—liver cancer	1.86e-05	0.000515	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—PIK3CD—liver cancer	1.85e-05	0.000514	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—ALB—liver cancer	1.83e-05	0.000508	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—H2AFX—liver cancer	1.78e-05	0.000495	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—PSMA4—liver cancer	1.77e-05	0.000492	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—PSMD10—liver cancer	1.77e-05	0.000492	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Platelet activation, signaling and aggregation—PIK3CA—liver cancer	1.76e-05	0.000489	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—GOT2—liver cancer	1.72e-05	0.000479	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A6—Transmembrane transport of small molecules—PPARA—liver cancer	1.71e-05	0.000475	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—PIK3CD—liver cancer	1.71e-05	0.000475	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—SERPINE1—liver cancer	1.69e-05	0.000469	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Transmembrane transport of small molecules—ALB—liver cancer	1.69e-05	0.000469	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—ALB—liver cancer	1.69e-05	0.000469	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—GSTP1—liver cancer	1.67e-05	0.000463	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—HMOX1—liver cancer	1.64e-05	0.000456	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—CYP2E1—liver cancer	1.62e-05	0.00045	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—MTHFR—liver cancer	1.62e-05	0.000449	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—PIK3CB—liver cancer	1.61e-05	0.000448	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—TERT—liver cancer	1.61e-05	0.000448	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—GSTM1—liver cancer	1.53e-05	0.000425	CbGpPWpGaD
Adefovir Dipivoxil—AK2—Metabolism—AKT1—liver cancer	1.53e-05	0.000425	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Transmembrane transport of small molecules—RAF1—liver cancer	1.53e-05	0.000424	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—RAF1—liver cancer	1.53e-05	0.000424	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A8—Transmembrane transport of small molecules—ALB—liver cancer	1.52e-05	0.000423	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—CYCS—liver cancer	1.52e-05	0.000421	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—PIK3CB—liver cancer	1.49e-05	0.000414	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—GGT1—liver cancer	1.49e-05	0.000413	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—GOT1—liver cancer	1.49e-05	0.000413	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Transmembrane transport of small molecules—ALB—liver cancer	1.46e-05	0.000406	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—CYP1A1—liver cancer	1.45e-05	0.000403	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Platelet activation, signaling and aggregation—AKT1—liver cancer	1.44e-05	0.0004	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A8—Transmembrane transport of small molecules—RAF1—liver cancer	1.38e-05	0.000383	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—IL2—liver cancer	1.37e-05	0.00038	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—APC—liver cancer	1.36e-05	0.000377	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—MTHFR—liver cancer	1.35e-05	0.000376	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—GSTP1—liver cancer	1.34e-05	0.000371	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—PPARA—liver cancer	1.33e-05	0.000369	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Transmembrane transport of small molecules—RAF1—liver cancer	1.32e-05	0.000367	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—HMOX1—liver cancer	1.32e-05	0.000366	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Metabolism—PIK3CA—liver cancer	1.3e-05	0.00036	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—BRAF—liver cancer	1.28e-05	0.000354	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A6—Transmembrane transport of small molecules—ALB—liver cancer	1.27e-05	0.000353	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—GSTM1—liver cancer	1.23e-05	0.000341	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—PIK3CD—liver cancer	1.19e-05	0.000332	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—SERPINE1—liver cancer	1.18e-05	0.000328	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—CYP1A1—liver cancer	1.16e-05	0.000323	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—VEGFA—liver cancer	1.16e-05	0.000323	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A6—Transmembrane transport of small molecules—RAF1—liver cancer	1.15e-05	0.000319	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—PIK3CG—liver cancer	1.14e-05	0.000316	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—PPARG—liver cancer	1.1e-05	0.000305	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—MTHFR—liver cancer	1.09e-05	0.000302	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—TGFB1—liver cancer	1.07e-05	0.000296	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—RAF1—liver cancer	1.07e-05	0.000296	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—PPARA—liver cancer	1.07e-05	0.000296	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Metabolism—AKT1—liver cancer	1.06e-05	0.000294	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—MTOR—liver cancer	1.04e-05	0.000289	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—PIK3CB—liver cancer	1.04e-05	0.000289	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—PIK3CD—liver cancer	1e-05	0.000278	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—KRAS—liver cancer	9.88e-06	0.000275	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—ALB—liver cancer	9.87e-06	0.000274	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—PIK3CA—liver cancer	9.84e-06	0.000273	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—CDKN1B—liver cancer	9.76e-06	0.000271	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—CTNNB1—liver cancer	9.22e-06	0.000256	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—PIK3CG—liver cancer	9.12e-06	0.000253	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—PIK3CA—liver cancer	9.08e-06	0.000252	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—CDKN1A—liver cancer	9.01e-06	0.00025	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—PPARG—liver cancer	8.8e-06	0.000244	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—TP53—liver cancer	8.78e-06	0.000244	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—PIK3CB—liver cancer	8.71e-06	0.000242	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—HRAS—liver cancer	8.4e-06	0.000233	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—STAT3—liver cancer	8.04e-06	0.000223	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—AKT1—liver cancer	8.04e-06	0.000223	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—PIK3CD—liver cancer	8.02e-06	0.000223	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—ALB—liver cancer	7.92e-06	0.00022	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—MYC—liver cancer	7.47e-06	0.000208	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—TGFB1—liver cancer	7.45e-06	0.000207	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—AKT1—liver cancer	7.42e-06	0.000206	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—PIK3CB—liver cancer	6.99e-06	0.000194	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—KRAS—liver cancer	6.9e-06	0.000192	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—PIK3CA—liver cancer	6.34e-06	0.000176	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—HRAS—liver cancer	5.87e-06	0.000163	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—IL6—liver cancer	5.62e-06	0.000156	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—PIK3CA—liver cancer	5.31e-06	0.000148	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—AKT1—liver cancer	5.18e-06	0.000144	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—AKT1—liver cancer	4.34e-06	0.000121	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—PIK3CA—liver cancer	4.26e-06	0.000118	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—AKT1—liver cancer	3.48e-06	9.67e-05	CbGpPWpGaD
